A randomised trial to assess the efficacy and safety of chlorproguanil/dapsone + artesunate for the treatment of uncomplicated Plasmodium falciparum malaria (Q38998772)

From Wikidata

Jump to navigation Jump to search

scientific article published on 6 March 2008

Language	Label	Description	Also known as
English	A randomised trial to assess the efficacy and safety of chlorproguanil/dapsone + artesunate for the treatment of uncomplicated Plasmodium falciparum malaria	scientific article published on 6 March 2008

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

A randomised trial to assess the efficacy and safety of chlorproguanil/dapsone + artesunate for the treatment of uncomplicated Plasmodium falciparum malaria (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Plasmodium falciparum

0 references

0 references

0 references

author name string

C I Fanello

1

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

C Karema

2

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

D Ngamije

3

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

A Uwimana

4

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

V Ndahindwa

5

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

C Van Overmeir

6

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

W Van Doren

7

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

J Curtis

8

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

U D'Alessandro

9

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

publication date

6 March 2008

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Transactions of the Royal Society of Tropical Medicine and Hygiene

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

102

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

412-420

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Chlorproguanil-dapsone for treating uncomplicated malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.013

7 January 2021

Transmission-blocking activities of quinine, primaquine, and artesunate

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.013

7 January 2021

In vivo selection for a specific genotype of dihydropteroate synthetase of Plasmodium falciparum by pyrimethamine-sulfadoxine but not chlorproguanil-dapsone treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.013

7 January 2021

A randomised trial to assess the safety and efficacy of artemether-lumefantrine (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwanda

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.013

7 January 2021

Impact of transmission intensity on the accuracy of genotyping to distinguish recrudescence from new infection in antimalarial clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.013

7 January 2021

Highly pyrimethamine-resistant alleles of dihydrofolate reductase in isolates of Plasmodium falciparum from Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.013

7 January 2021

Safety and efficacy of dihydroartemisinin/piperaquine (Artekin) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan children

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.013

7 January 2021

Artesunate-dapsone-proguanil treatment of falciparum malaria: genotypic determinants of therapeutic response

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.013

7 January 2021

Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.013

7 January 2021

Artemisinin: mechanisms of action, resistance and toxicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.013

7 January 2021

Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.013

7 January 2021

Genetic diversity of Plasmodium falciparum parasites from Kenya is not affected by antifolate drug selection

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.013

7 January 2021

Why has the dihydrofolate reductase 164 mutation not consistently been found in Africa yet?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.013

7 January 2021

Activities of artesunate and primaquine against asexual- and sexual-stage parasites in falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.013

7 January 2021

Is amodiaquine failing in Rwanda? Efficacy of amodiaquine alone and combined with artesunate in children with uncomplicated malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.013

7 January 2021

Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.013

7 January 2021

Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.013

7 January 2021

The efficacy of antifolate antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analyses

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.013

7 January 2021

Poor efficacy of antimalarial biguanide-dapsone combinations in the treatment of acute, uncomplicated, falciparum malaria in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.013

7 January 2021

Chlorproguanil-dapsone (LAPDAP) for uncomplicated falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.013

7 January 2021

Chlorproguanil/dapsone for uncomplicated Plasmodium falciparum malaria in young children: pharmacokinetics and therapeutic range

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2008.01.013

7 January 2021

Identifiers

10.1016/J.TRSTMH.2008.01.013

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38998772&oldid=1801656438"